CO4940492A1 - Inhibidor de proteasa de vih - Google Patents

Inhibidor de proteasa de vih

Info

Publication number
CO4940492A1
CO4940492A1 CO98029716A CO98029716A CO4940492A1 CO 4940492 A1 CO4940492 A1 CO 4940492A1 CO 98029716 A CO98029716 A CO 98029716A CO 98029716 A CO98029716 A CO 98029716A CO 4940492 A1 CO4940492 A1 CO 4940492A1
Authority
CO
Colombia
Prior art keywords
crystalline compound
compound
solution
formula
protease inhibitor
Prior art date
Application number
CO98029716A
Other languages
English (en)
Inventor
David Askin
Scott Hoerrner R
Robert M Purick
Paul Reider
Varsolona Richard J
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CO4940492A1 publication Critical patent/CO4940492A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto cristalino de fórmula:en donde el compuesto cristalino es caracterizado por (i) una curva de barrido diferencial de calorimetría (DSC), a una tasa de calentamiento de 10 °C/minuto en una taza abierta, bajo flujo de nitrógeno, que exhibe una endoterma con una temperatura extrapolada de inicio de 190°C, una temperatura pico de 193°C y un calor asociado de 120 J/gm y (ii) un patrón de difracción del polvo a los rayos X con espaciamientos-d de 11,72 Å (11,72* 10-8 cm), 5,56 Å (5,56* 10-8 cm), 5,20 Å (5,20* 10-8 cm), 5,00 Å (5,00*10-8 cm), 4,60 Å (4,60*10-8 cm), 4,50 Å (4,50*10-8 cm), 4,40 Å (4,40*10-8 cm), 4,26 Å (4,26*10-8 cm), 4,17 Å (4,17*10-8 cm), 4,08 Å (4,08*10-8 cm), 3,90 Å (3,90*10-8 cm), 3,81 Å (3,81*10-8 cm), 3,69 Å (3,69*10-8 cm), 3,24 Å (3,24*10-8 cm) y 3,33 Å (3,33*10-8 cm).1Un procedimiento para preparar el compuesto cristalino de la reivindicación 1, que comprende: (a) disolver el compuesto de base libre del compuesto de fórmula: en un solvente para formar una solución; y (b) tratar la solución del paso (a) con ácido sulfúrico para formar el compuesto cristalino.
CO98029716A 1997-05-29 1998-05-27 Inhibidor de proteasa de vih CO4940492A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4795097P 1997-05-29 1997-05-29

Publications (1)

Publication Number Publication Date
CO4940492A1 true CO4940492A1 (es) 2000-07-24

Family

ID=21951924

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98029716A CO4940492A1 (es) 1997-05-29 1998-05-27 Inhibidor de proteasa de vih

Country Status (3)

Country Link
US (1) US6071916A (es)
CO (1) CO4940492A1 (es)
ZA (1) ZA984514B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336699B1 (ko) 1992-08-25 2002-05-13 윌리암스 로저 에이 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드
US6482827B1 (en) * 1997-07-10 2002-11-19 Pharmacia & Upjohn S.P.A. Matrix metalloproteinase inhibitors
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7049146B2 (en) 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
NZ536497A (en) * 2002-05-16 2006-08-31 Tibotec Pharm Ltd Pseudopolymorphic forms of a HIV protease inhibitor and their use as a medicament
US20040131504A1 (en) * 2002-09-17 2004-07-08 Landers James P. Remote temperature sensing of small volume and related apparatus thereof
CA2531116A1 (en) * 2003-07-01 2005-01-20 Michael Hawley Diffusion layer modulated solids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US5717097A (en) * 1991-11-08 1998-02-10 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
AU692509B2 (en) * 1993-12-15 1998-06-11 Merck & Co., Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
ZA984514B (en) 1998-11-30
US6071916A (en) 2000-06-06

Similar Documents

Publication Publication Date Title
CO4940492A1 (es) Inhibidor de proteasa de vih
Oakes et al. 853. Polyazanaphthalenes. Part IV. Further derivatives of 1: 3: 5-and 1: 3: 8-triazanaphthalene
GB1111507A (en) Substituted amino pyridines
GB1494823A (en) Process for the production of 2-aryl-2h-benzotriazoles
ES431312A1 (es) Procedimiento de preparacion de nuevos derivados de la fe- nil propenilamina.
GB964143A (en) Substituted quinolines
US3574739A (en) Alkoxybenzenesulfonamides
US2441576A (en) Amino methyl phenols
SU637085A3 (ru) Способ получени /+/-/ /энантиомера 3- 2- 4-(8-фтор-10,11-дигидро-2-метил-дибензо( )тиепин-10-ил) -1-пиперазинил -этил -2-оксазолидинона или его солей
Whaley et al. 217. The synthesis and resolution of (±)-corlumine
Karim et al. Potential Reserpine Analogues: Part I. Derivatives of Tryptamine
US2663709A (en) 1-alkyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline compounds
US2348425A (en) Antivitamin
US1958529A (en) Basic product from dmino ethers of
PT71600A (en) Process for preparing new 3-amino-1-benzoxepen derivatives
US2474719A (en) Method for separating the stereoisomers of alpha-hydroxy-beta, beta-dimethylgamma-butyrolactone
RO80266B (ro) Procedeu pentru prepararea unor derivati de 1-amino-2-propanol
GB1073447A (en) Improvements in or relating to pyrido [4,3-b] indole derivatives
US3055937A (en) Substituted glycineamides
GB1041696A (en) Manufacture of benzo[a]quinolizines
GB1112087A (en) New pyridazone derivatives and process for preparing same
US2486375A (en) Alicyclic (secondary) amino alkyl benzoates
RO68380B (ro) Procedeu pentru prepararea n-1-(3, 4-metilendioxifenil)-propil(2)-fenilpiperazine substituite
US3239526A (en) 3-phenyl-4-aminocinnolines
Gump et al. Adrenergic Blocking Agents. II. N-(2-Chloroethyl)-N-(2-phenoxyethyl)-amine Hydrochlorides1